Blog
Crushing Systems and USP 800 Compliance
https://www.pharmacytimes.com/view/crushing-systems-and-usp-800-compliance
Crushing Systems and USP 800 Compliance
https://www.pharmacytimes.com/view/crushing-systems-and-usp-800-compliance
USP<797> Pill Crushing, RxCrush
Millions of doses of medications are compounded each year in the United States. Its estimated that as many as 190,000,000 are prepared each year. Drug compounding is the process of...
USP<797> Pill Crushing, RxCrush
Millions of doses of medications are compounded each year in the United States. Its estimated that as many as 190,000,000 are prepared each year. Drug compounding is the process of...
GEDSA Supports FDA Safety Communication on ENFi...
GEDSA Supports FDA Safety Communication on ENFit® Low Dose Tip Syringe Proper Labelling and Training Materials Requested from ManufacturersNovember 02, 2021 11:44 AM Eastern Daylight Time POWELL, Ohio--(BUSINESS WIRE)--On October...
GEDSA Supports FDA Safety Communication on ENFi...
GEDSA Supports FDA Safety Communication on ENFit® Low Dose Tip Syringe Proper Labelling and Training Materials Requested from ManufacturersNovember 02, 2021 11:44 AM Eastern Daylight Time POWELL, Ohio--(BUSINESS WIRE)--On October...
USP<800>, Pill Crushing, and RxCrush-Guidance a...
The U.S. Pharmacopeial Convention (USP) recently updated their General Chapter USP<800> in December of 2019. USP General Chapter 800 sets the standards of how to handle hazardous drugs in clinical...
USP<800>, Pill Crushing, and RxCrush-Guidance a...
The U.S. Pharmacopeial Convention (USP) recently updated their General Chapter USP<800> in December of 2019. USP General Chapter 800 sets the standards of how to handle hazardous drugs in clinical...
ENFit LDT Syringes
The FDA continues to recommend the use of enteral devices and syringes that reduce the risk of misconnections, such as ENFit LDT syringes.https://www.businesswire.com/news/home/20211102005986/en/GEDSA-Supports-FDA-Safety-Communication-on-ENFit%C2%AE-Low-Dose-Tip-Syringe
ENFit LDT Syringes
The FDA continues to recommend the use of enteral devices and syringes that reduce the risk of misconnections, such as ENFit LDT syringes.https://www.businesswire.com/news/home/20211102005986/en/GEDSA-Supports-FDA-Safety-Communication-on-ENFit%C2%AE-Low-Dose-Tip-Syringe